A recent study indicates that patients who come off popular GLP-1 drugs like Mounjaro or Wegovy tend to recover lost weight far faster than those who end traditional diet and exercise regimens.
Findings released in a prominent health publication shows that while overweight people can lose about a fifth of their body weight while undergoing treatment, the weight returns at an estimated rate of 0.8 kg per month upon discontinuation.
"People using these treatments need to be cognizant of the risk of quick weight regain when the therapy is stopped," warns lead investigator Dr. Susan Jebb.
Such speed of recovery suggests a reversion to starting mass in about a year and a half.
Comparing Therapies
The study, which examined dozens of trials involving over 9,000 of patients, contrasted the outcomes of these new drugs with other pills.
The team emphasize that individuals who shed pounds through diet and exercise generally have a slower creep back—perhaps 0.1 kg a month—after stopping.
Explaining the Rapid Rebound
Doctors suggest the way of the injections explains the accelerated regain.
The injections imitate a natural hormone called glucagon-like peptide-1, which controls appetite.
"Artificially providing GLP-1 concentrations far above than normal may cause the system to generate a reduced amount of its endogenous GLP-1, and may also reduce sensitivity to its effects," said Dr. Adam Collins, a nutrition researcher.
"Stopping of this medication leads to appetite is uncontrolled, making excessive eating far more likely."
A Chronic Issue?
Medical guidelines advise the injections for individuals with weight-linked medical conditions, accompanied by recommended diet and exercise modifications.
Professionals contend that, due to the high risk of weight regain, the therapy should be considered ongoing.
This perspective is echoed by pharmaceutical companies, who note that the results "highlight the long-term nature of excess weight," akin to managing conditions like high blood pressure.
User Testimonies
Users who have discontinued the jabs report a powerful return of hunger.
"It felt as if a switch that goes on and you become starving," described an individual.
The struggle is worsened if patients have not established lasting lifestyle or habit modifications during therapy.
Widespread Use
Recent estimates indicate that millions of people in the UK have tried weight-loss jabs in the past year, with demand being substantial.
- Use is higher among women compared to males.
- The middle-aged demographic shows the greatest level of interest.
- A large proportion obtain the medications through private prescriptions rather than public health services.
In conclusion, clinicians caution that while these medications are potent tools for weight loss, they are not a magic solution and lasting health benefits hinges on combined lifestyle support.
